Top Abstract Purchase Related
Home
>
Node
>
Subnode

Overcoming drug resistance in lung cancer

Saijo, N.; Nishio, K.; Yoshida, M.

Oncology 12(1 Suppl 2: 87-89

1998

ISSN/ISBN: 0890-9091
PMID: 9516619
Document Number: 496802
Anticancer drugs have been explored by means of random screening and demonstrated to be active against not only hematologic malignancies but also some solid tumors. Recent progress in the field of molecular biology has identified many new molecular targets for anticancer drugs. In this review, for example, signal-transduction pathways, which are influenced by newer agents like the taxanes (paclitaxel [Taxol] and docetaxel [Taxotere]) and the protein kinase C activator gnidimacrin, are evaluated. Efforts under way to integrate these new compounds into clinical trials are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Takeda, K. 2009: Overcoming resistance to EGFR-TKi in lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(4): 552-556
Oguri, T.; Fujiwara, Y.; Ochiai, M.; Fujitaka, K.; Miyazaki, M.; Takahashi, T.; Yokozaki, M.; Isobe, T.; Ohune, T.; Tsuya, T.; Katoh, O.; Yamakido, M. 1998: Expression of lung-resistance protein gene is not associated with platinum drug exposure in lung cancer Anticancer Research 18(6a): 4159-4162
Harada, T.; Hara, N. 2002: Drug resistance in lung cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 5): 317-321
Grishin, M.N.; Svistov, V.V.; Krivoshein, I.S. 2002: Ways of overcoming drug resistance in patients with pulmonary tuberculosis Problemy Tuberkuleza 3: 16-18
Wu, Q.-g.; Cao, T.-t.; Cheng, Z.; Wang, J. 2011: Effects of Akt2-siRNA on chemotherapeutic sensitivity and drug resistance in human lung cancer cells Zhonghua Yi Xue Za Zhi 91(30): 2139-2142
Gao, Z.; Gao, Z.; Fields, J.Z.; Boman, B.M. 1998: Co-transfection of MDR1 and MRP antisense RNAs abolishes the drug resistance in multidrug-resistant human lung cancer cells Anticancer Research 18(4c): 3073-3076
Paterson, J.; Uriel, C.; Egron, M.J.; Herscovici, J.; Antonakis, K.; Alaoui-Jamali, M.A. 1998: Antiproliferative and apoptotic activities of ketonucleosides and keto-C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance Antimicrobial Agents and ChemoTherapy 42(4): 779-784
Volm, M.; Bak, M.; Mattern, J. 1988: Intrinsic drug resistance in a human lung carcinoma xenograft is associated with overexpression of multidrug-resistance DNA-sequences and of plasma membrane glycoproteins Arzneimittel-Forschung 38(8): 1189-1193
Zhu, H.-B.; Huang, X.-F.; Hu, J.-Z.; Zhou, W.; Chen, W.; Chen, L.-L.; He, C. 2008: Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer Zhonghua Zhong Liu Za Zhi 30(4): 245-249
Fujita, F.; Fujita, M.; Fujita, M.; Sakamoto, Y. 1994: Acquired resistance and cross-resistance of gemcitabine to cisplatin or vindesine in human lung cancer xenografted in nude mice Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2749-2755
Keizer, H.G.; Schuurhuis, G.J.; Broxterman, H.J.; Lankelma, J.; Schoonen, W.G.; van Rijn, J.; Pinedo, H.M.; Joenje, H. 1989: Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells Cancer Research 49(11): 2988-2993
Baas, F.; Jongsma, A.P.; Broxterman, H.J.; Arceci, R.J.; Housman, D.; Scheffer, G.L.; Riethorst, A.; van Groenigen, M.; Nieuwint, A.W.; Joenje, H. 1990: Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line Cancer Research 50(17): 5392-5398
Aoe, K.; Hiraki, A.; Murakami, T.; Maeda, T.; Umemori, Y.; Katayama, H.; Eda, R.; Takeyama, H. 2005: Sudden onset of interstitial lung disease induced by gefitinib in a lung cancer patient with multiple drug allergy Anticancer Research 25(1b): 415-418
Knibbe, H. 1992: Overcoming resistance. Mind your back Nursing Times 88(52): 46-47
de la Torre, M.; Hao, X.Y.; Larsson, R.; Nygren, P.; Tsuruo, T.; Mannervik, B.; Bergh, J. 1993: Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases Anticancer Research 13(5a): 1425-1430
Lyshak, F.; Bassin, D.; Robbins, A. 1981: The creative act as a means of overcoming resistance in treatment Psychoanalytic Review 68(3): 395-407
McIntosh, E.; David, G. 2007: New antibiotics, efflux pumps and overcoming resistance Casopis Lekaru Ceskych 146(2): 102-106; Discussion: 107-108
Brattain, M.G.; Willson, J.K.; Long, B.H.; Chakrabarty, S.; Yeoman, L.C.; Stringfellow, D.A. 1986: Overcoming mitomycin C resistance with semisynthetic derivatives Progress in Clinical and Biological Research 223: 63-79
Pillay, D.; Albert, J.; Bertagnolio, S.; Boucher, C.; Brun-Vezinet, F.; Clotet, B.; Giaquinto, C.; Perno, C.F. 2013: Implications of HIV drug resistance on first- and second-line therapies in resource-limited settings: report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network Antiviral Therapy 18(6): 831-836
Hamers, R.L.; Schuurman, R.; Sigaloff, K.C.E.; Wallis, C.L.; Kityo, C.; Siwale, M.; Mandaliya, K.; Ive, P.; Botes, M.E.; Wellington, M.; Osibogun, A.; Wit, F.W.; van Vugt, M.èl.; Stevens, W.S.; de Wit, T.F.R. 2012: Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study LANCET. Infectious Diseases 12(4): 307-317